CA2236592C - Synergistic herbicidal mixtures - Google Patents

Synergistic herbicidal mixtures Download PDF

Info

Publication number
CA2236592C
CA2236592C CA002236592A CA2236592A CA2236592C CA 2236592 C CA2236592 C CA 2236592C CA 002236592 A CA002236592 A CA 002236592A CA 2236592 A CA2236592 A CA 2236592A CA 2236592 C CA2236592 C CA 2236592C
Authority
CA
Canada
Prior art keywords
rates
colby
dosage
mixtures
loo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002236592A
Other languages
English (en)
French (fr)
Other versions
CA2236592A1 (en
Inventor
Richard Rees
Jurgen Bohner
Eberhard Richter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yashima Chemical Industrial Co Ltd
Original Assignee
Hoechst Schering Agrevo GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Schering Agrevo GmbH filed Critical Hoechst Schering Agrevo GmbH
Publication of CA2236592A1 publication Critical patent/CA2236592A1/en
Application granted granted Critical
Publication of CA2236592C publication Critical patent/CA2236592C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
CA002236592A 1995-11-15 1996-11-12 Synergistic herbicidal mixtures Expired - Lifetime CA2236592C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19544393A DE19544393A1 (de) 1995-11-15 1995-11-15 Synergistische herbizide Mischungen
DE19544393.4 1995-11-15
PCT/EP1996/004935 WO1997017852A1 (de) 1995-11-15 1996-11-12 Synergistische herbizide mischungen

Publications (2)

Publication Number Publication Date
CA2236592A1 CA2236592A1 (en) 1997-05-22
CA2236592C true CA2236592C (en) 2005-01-04

Family

ID=7778639

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002236592A Expired - Lifetime CA2236592C (en) 1995-11-15 1996-11-12 Synergistic herbicidal mixtures

Country Status (18)

Country Link
US (1) US6013605A (enExample)
EP (1) EP0863705B1 (enExample)
JP (1) JP3920341B2 (enExample)
KR (1) KR100427960B1 (enExample)
CN (1) CN1084148C (enExample)
AU (1) AU711841B2 (enExample)
BR (1) BR9611478A (enExample)
CA (1) CA2236592C (enExample)
DE (2) DE19544393A1 (enExample)
ES (1) ES2178720T3 (enExample)
MX (1) MX9803824A (enExample)
MY (1) MY114731A (enExample)
RU (1) RU2170017C2 (enExample)
TR (1) TR199800794T2 (enExample)
TW (1) TW355125B (enExample)
UA (1) UA48203C2 (enExample)
WO (1) WO1997017852A1 (enExample)
ZA (1) ZA969564B (enExample)

Families Citing this family (255)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19836684A1 (de) 1998-08-13 2000-02-17 Hoechst Schering Agrevo Gmbh Herbizide Mittel für tolerante oder resistente Reiskulturen
KR100338621B1 (ko) * 2000-01-24 2002-05-30 전광술 제초제 및 그 제조방법
US20070160576A1 (en) 2001-06-05 2007-07-12 Genentech, Inc. IL-17A/F heterologous polypeptides and therapeutic uses thereof
PT2000545E (pt) 2001-06-20 2011-12-21 Genentech Inc Composições e métodos para o diagnóstico e tratamento do tumor pulmonar
ES2266618T3 (es) 2001-08-23 2007-03-01 Bayer Cropscience S.A. Propargilaminas substituidas.
JP2005536439A (ja) 2001-09-18 2005-12-02 ジェネンテック・インコーポレーテッド 腫瘍の診断及び治療のための組成物と方法
KR100623128B1 (ko) 2002-01-02 2006-09-14 제넨테크, 인크. 종양의 진단 및 치료 방법 및 이를 위한 조성물
KR100429139B1 (ko) * 2002-02-28 2004-04-29 한국화학연구원 싸이할로호프와 메타미호프를 유효성분으로 하는 제초제조성물 및 이를 이용하여 화본과 잡초를 방제하는 방법
NZ535925A (en) 2002-04-16 2008-06-30 Genentech Inc An isolated antibody that binds to a particular polypeptide
EP2305710A3 (en) 2002-06-03 2013-05-29 Genentech, Inc. Synthetic antibody phage libraries
JP4869064B2 (ja) 2003-04-04 2012-02-01 ジェネンテック, インコーポレイテッド 高濃度抗体及びタンパク質製剤
US6849579B2 (en) * 2003-06-25 2005-02-01 Pbi Gordon Corporation Synergistic quinclorac herbicidal compositions
HUE045709T2 (hu) 2003-07-08 2020-01-28 Genentech Inc Antagonista antitestek IL-17A/F heterológ polipeptidekhez
NZ547558A (en) 2003-11-17 2009-06-26 Genentech Inc Compositions and methods for the treatment of tumor of hematopoietic origin
JP4570890B2 (ja) * 2004-03-26 2010-10-27 協友アグリ株式会社 除草剤組成物
US20060051347A1 (en) 2004-09-09 2006-03-09 Winter Charles M Process for concentration of antibodies and therapeutic products thereof
KR20130089280A (ko) 2005-01-21 2013-08-09 제넨테크, 인크. Her 항체의 고정 용량 투여법
ES2440481T3 (es) 2005-02-23 2014-01-29 Genentech, Inc. Prolongación del tiempo hasta la progresión de la enfermedad o supervivencia en pacientes de cáncer de ovario usando pertuzumab
US20090136505A1 (en) 2005-02-23 2009-05-28 Johanna Bentz Intranasal Administration of Active Agents to the Central Nervous System
BRPI0608309A2 (pt) 2005-02-23 2009-12-08 Alza Corp administração intranasal de agentes ativos ao sistema nervoso central
US7521425B2 (en) 2005-03-03 2009-04-21 Covx Technologies Ireland Limited Anti-angiogenic compounds
CA2610709A1 (en) 2005-06-06 2006-12-14 Genentech, Inc. Transgenic models for different genes and their use for gene characterization
JP2009504183A (ja) 2005-08-15 2009-02-05 ジェネンテック・インコーポレーテッド 遺伝子破壊、それに関連する組成物および方法
ZA200804162B (en) 2005-11-21 2009-12-30 Genentech Inc Novel gene disruptions, compositions and methods relating thereto
JP2009527227A (ja) 2006-02-17 2009-07-30 ジェネンテック・インコーポレーテッド 遺伝子破壊、それに関連する組成物および方法
ES2544957T3 (es) 2006-03-21 2015-09-07 Genentech, Inc. Terapia combinada que implica antagonistas alfa5beta1
EP2007428A2 (en) 2006-04-05 2008-12-31 Genentech, Inc. Method for using boc/cdo to modulate hedgehog signaling
AU2007297565A1 (en) 2006-04-19 2008-03-27 Genentech, Inc. Novel gene disruptions, compositions and methods relating thereto
NZ572177A (en) 2006-06-06 2012-02-24 Genentech Inc Anti-dll4 antibodies and methods using same
US8874380B2 (en) 2010-12-09 2014-10-28 Rutgers, The State University Of New Jersey Method of overcoming therapeutic limitations of nonuniform distribution of radiopharmaceuticals and chemotherapy drugs
WO2008021290A2 (en) 2006-08-09 2008-02-21 Homestead Clinical Corporation Organ-specific proteins and methods of their use
EP2059533B1 (en) 2006-08-30 2012-11-14 Genentech, Inc. Multispecific antibodies
US8288349B2 (en) 2006-11-10 2012-10-16 Covx Technology Ireland, Ltd. Anti-angiogenic compounds
KR101508397B1 (ko) 2007-02-22 2015-04-08 제넨테크, 인크. 염증성 장 질환의 검출 방법
US7960139B2 (en) 2007-03-23 2011-06-14 Academia Sinica Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
PL2171090T3 (pl) 2007-06-08 2013-09-30 Genentech Inc Markery ekspresji genów odporności guza na leczenie hamujące HER2
EP2176295B1 (en) 2007-07-16 2014-11-19 Genentech, Inc. Humanized anti-cd79b antibodies and immunoconjugates and methods of use
JP5469600B2 (ja) 2007-07-16 2014-04-16 ジェネンテック, インコーポレイテッド 抗CD79b抗体及びイムノコンジュゲートとその使用方法
EP2222875B1 (en) 2007-11-07 2014-08-20 Genentech, Inc. Methods and compositions for assessing responsiveness of b-cell lymphoma to treatment with anti-cd40 antibodies
WO2010135521A2 (en) 2009-05-20 2010-11-25 Theraclone Sciences, Inc. Compositions and methods for the therapy and diagnosis of influenza
US8057796B2 (en) 2007-11-12 2011-11-15 Theraclone Sciences, Inc. Compositions and methods for the therapy and diagnosis of influenza
ES2643239T3 (es) 2008-01-31 2017-11-21 Genentech, Inc. Anticuerpos anti-CD79b e inmunoconjugados y métodos de uso
US7982012B2 (en) 2008-03-10 2011-07-19 Theraclone Sciences, Inc. Compositions and methods for the therapy and diagnosis of cytomegalovirus
MX348362B (es) 2008-03-31 2017-06-07 Genentech Inc * Composiciones y metodos para tratar y diagnosticar asma.
US20100255508A1 (en) 2008-05-16 2010-10-07 Thomas Richard Gelzleichter Use of biomarkers for assessing treatment of gastrointestinal inflammatory disorders with beta7 integrin antagonists
MX2011000233A (es) 2008-07-08 2011-05-19 Oncomed Pharm Inc Agentes de union del receptor notch1 y metodos para su uso.
JP5986745B2 (ja) 2008-07-15 2016-09-06 アカデミア シニカAcademia Sinica Ptfe様のアルミニウム・コート・ガラススライド上のグリカンアレイおよび関連する方法
CN101352171B (zh) * 2008-09-19 2012-07-04 北京燕化永乐农药有限公司 吡嘧磺隆与甲羧除草醚农药的除草剂组合物
AU2009313902B9 (en) 2008-11-13 2014-03-27 The General Hospital Corporation Methods and compositions for regulating iron homeostasis by modulation of BMP-6
US8211434B2 (en) 2008-11-26 2012-07-03 Allergan, Inc. KLK-13 antibody inhibitor for treating dry eye
TWI605828B (zh) 2008-12-09 2017-11-21 建南德克公司 抗pd-l1抗體及其於增進t細胞功能之用途
SI3260136T1 (sl) 2009-03-17 2021-05-31 Theraclone Sciences, Inc. Humani imunodeficientni virus (HIV)-nevtralizirajoča protitelesa
CA2755640C (en) 2009-03-20 2018-05-22 Genentech, Inc. Bispecific antibody with a single antigen-binding domain specific for both her3 and egfr
EP2414399A1 (en) 2009-04-01 2012-02-08 F. Hoffmann-La Roche AG Anti-fcrh5 antibodies and immunoconjugates and methods of use
AU2010232692C1 (en) 2009-04-01 2017-06-01 Genentech, Inc. Treatment of insulin-resistant disorders
US20100297127A1 (en) 2009-04-08 2010-11-25 Ghilardi Nico P Use of il-27 antagonists to treat lupus
JP5836929B2 (ja) 2009-04-18 2015-12-24 ジェネンテック, インコーポレイテッド 抗cd40抗体を用いる治療に対するb細胞性リンパ腫の応答性を評価するための方法
CA2759506A1 (en) 2009-04-23 2010-10-28 Theraclone Sciences, Inc. Granulocyte-macrophage colony-stimulating factor (gm-csf) neutralizing antibodies
WO2011019679A1 (en) 2009-08-11 2011-02-17 Allergan, Inc. Ccr2 inhibitors for treating conditions of the eye
JP5819308B2 (ja) 2009-10-22 2015-11-24 ジェネンテック, インコーポレイテッド マクロファージ刺激タンパク質のヘプシン活性化を調節するための方法及び組成物
WO2011056502A1 (en) 2009-10-26 2011-05-12 Genentech, Inc. Bone morphogenetic protein receptor type ii compositions and methods of use
WO2011056494A1 (en) 2009-10-26 2011-05-12 Genentech, Inc. Activin receptor-like kinase-1 antagonist and vegfr3 antagonist combinations
DK2494356T3 (en) 2009-10-26 2017-05-15 Genentech Inc ASSAYS FOR THE DETECTION OF ANTIBODIES SPECIFIC TO THERAPEUTIC ANTI-IGE ANTIBODIES AND THEIR USE OF ANAPHYLAXY
WO2011056497A1 (en) 2009-10-26 2011-05-12 Genentech, Inc. Activin receptor type iib compositions and methods of use
CA2781887C (en) 2009-11-30 2018-03-27 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
US20110159588A1 (en) 2009-12-30 2011-06-30 Kui Lin Methods for Modulating a PDGF-AA Mediated Biological Response
MX2012009215A (es) 2010-02-23 2012-11-23 Genentech Inc Composiciones y metodos para el diagnostico y tratamiento de tumores.
WO2011130332A1 (en) 2010-04-12 2011-10-20 Academia Sinica Glycan arrays for high throughput screening of viruses
WO2011133931A1 (en) 2010-04-22 2011-10-27 Genentech, Inc. Use of il-27 antagonists for treating inflammatory bowel disease
CA2794864A1 (en) 2010-05-03 2011-11-10 Genentech, Inc. Compositions and methods useful for reducing the viscosity of protein-containing formulations
CA2835489C (en) 2010-05-10 2018-03-06 Chi-Huey Wong Zanamivir phosphonate congeners with anti-influenza activity and determining oseltamivir susceptibility of influenza viruses
CN102265853A (zh) * 2010-06-04 2011-12-07 南京华洲药业有限公司 一种含灭草松和二氯喹啉酸的除草组合物及其应用
US20110311527A1 (en) 2010-06-16 2011-12-22 Allergan, Inc. IL23p19 ANTIBODY INHIBITOR FOR TREATING OCULAR AND OTHER CONDITIONS
EP2420250A1 (en) 2010-08-13 2012-02-22 Universitätsklinikum Münster Anti-Syndecan-4 antibodies
JP2013540701A (ja) 2010-08-12 2013-11-07 セラクローン サイエンシーズ, インコーポレイテッド 抗赤血球凝集素抗体組成物およびその使用方法
JP2013537416A (ja) 2010-08-13 2013-10-03 メディミューン リミテッド 変異型Fc領域を含むモノマーポリペプチド及び使用方法
WO2012022734A2 (en) 2010-08-16 2012-02-23 Medimmune Limited Anti-icam-1 antibodies and methods of use
CA2809837C (en) 2010-08-31 2019-12-31 Theraclone Sciences, Inc. Human immunodeficiency virus (hiv)-neutralizing antibodies
WO2012092539A2 (en) 2010-12-31 2012-07-05 Takeda Pharmaceutical Company Limited Antibodies to dll4 and uses thereof
JP2014506580A (ja) 2011-02-14 2014-03-17 セラクローン サイエンシーズ, インコーポレイテッド インフルエンザの治療および診断のための組成物および方法
JP2014509591A (ja) 2011-03-15 2014-04-21 セラクローン サイエンシーズ, インコーポレイテッド インフルエンザの治療および診断のための組成物および方法
MY189494A (en) 2011-03-31 2022-02-16 Genentech Inc Methods of administering beta7 integrin antagonists
BR122020001787A8 (pt) 2011-05-08 2023-04-25 Legochem Biosciences Inc Conjugado de anticorpo-agente ativo, seus métodos de preparação, sua composição e seu uso
EA201990685A1 (ru) 2011-05-17 2019-12-30 Дзе Рокфеллер Юниверсити Нейтрализующие вирус иммунодефицита человека антитела и способы их применения
CA2836373A1 (en) 2011-06-06 2012-12-13 Neotope Biosciences Limited Mcam antagonists and methods of treatment
JP2013040160A (ja) 2011-07-01 2013-02-28 Genentech Inc 自己免疫疾患を治療するための抗cd83アゴニスト抗体の使用
US9120858B2 (en) 2011-07-22 2015-09-01 The Research Foundation Of State University Of New York Antibodies to the B12-transcobalamin receptor
WO2013015821A1 (en) 2011-07-22 2013-01-31 The Research Foundation Of State University Of New York Antibodies to the b12-transcobalamin receptor
US9493549B2 (en) 2011-07-25 2016-11-15 The Rockefeller University Antibodies directed toward the HIV-1 GP120 CD4 binding site with increased potency and breadth
WO2013016468A2 (en) 2011-07-25 2013-01-31 California Institute Of Technology Compositions and methods for improving potency and breadth or hiv antibodies
WO2013033069A1 (en) 2011-08-30 2013-03-07 Theraclone Sciences, Inc. Human rhinovirus (hrv) antibodies
US20150011431A1 (en) 2012-01-09 2015-01-08 The Scripps Research Institute Humanized antibodies
CN104520321A (zh) 2012-01-09 2015-04-15 斯克利普斯研究所 超长互补决定区及其用途
TW201334789A (zh) 2012-01-31 2013-09-01 Genentech Inc 抗ige抗體及其使用方法
RU2014139546A (ru) 2012-03-27 2016-05-20 Дженентек, Инк. Методы прогнозирования, диагностики и лечения идиопатического легочного фиброза
JP2015514710A (ja) 2012-03-27 2015-05-21 ジェネンテック, インコーポレイテッド Her3阻害剤に関する診断及び治療
US10130714B2 (en) 2012-04-14 2018-11-20 Academia Sinica Enhanced anti-influenza agents conjugated with anti-inflammatory activity
US9879068B2 (en) 2012-06-21 2018-01-30 California Institute Of Technology Antibodies targeting HIV escape mutants
WO2014018375A1 (en) 2012-07-23 2014-01-30 Xenon Pharmaceuticals Inc. Cyp8b1 and uses thereof in therapeutic and diagnostic methods
US9914956B2 (en) 2012-08-18 2018-03-13 Academia Sinica Cell-permeable probes for identification and imaging of sialidases
CA2883168A1 (en) 2012-08-21 2014-02-27 Academia Sinica Benzocyclooctyne compounds and uses thereof
TWI595007B (zh) 2012-09-10 2017-08-11 Neotope Biosciences Ltd 抗mcam抗體及相關使用方法
BR112015007528A2 (pt) 2012-10-05 2018-09-04 Genentech Inc método para prever a resposta, para prever a responsividade, para identificar e para tratar um paciente que tem uma disfunção inflamatória gastrointestinal.
SI2908912T1 (sl) 2012-10-18 2021-03-31 The Rockefeller University Široko nevtralizirajoča protitelesa proti HIV
AU2013334493B2 (en) 2012-10-26 2018-11-29 The University Of Queensland Use of endocytosis inhibitors and antibodies for cancer therapy
CA2904095A1 (en) 2013-03-27 2014-10-02 Genentech, Inc. Use of biomarkers for assessing treatment of gastrointestinal inflammatory disorders with beta7 integrin antagonists
US20160053023A1 (en) 2013-04-09 2016-02-25 Annexon, Inc. Methods of treatment for neuromyelitis optica
WO2014210397A1 (en) 2013-06-26 2014-12-31 Academia Sinica Rm2 antigens and use thereof
WO2014210564A1 (en) 2013-06-27 2014-12-31 Academia Sinica Glycan conjugates and use thereof
SG10201710758PA (en) 2013-07-09 2018-02-27 Annexon Inc Anti-complement factor c1q antibodies and uses thereof
CN111518199A (zh) 2013-07-18 2020-08-11 图鲁斯生物科学有限责任公司 具有超长互补决定区的人源化抗体
US20160168231A1 (en) 2013-07-18 2016-06-16 Fabrus, Inc. Antibodies with ultralong complementarity determining regions
KR102298172B1 (ko) 2013-09-06 2021-09-06 아카데미아 시니카 변화된 글리코실 그룹을 갖는 당지질을 사용한 인간 iNKT 세포 활성화
WO2015050959A1 (en) 2013-10-01 2015-04-09 Yale University Anti-kit antibodies and methods of use thereof
MX380937B (es) 2013-12-20 2025-03-12 Genentech Inc Anticuerpos dobles especificos.
AU2015206788B2 (en) 2014-01-14 2019-10-24 The Medical College Of Wisconsin, Inc. Targeting CLPTM1L for treatment and prevention of cancer
CA2937123A1 (en) 2014-01-16 2015-07-23 Academia Sinica Compositions and methods for treatment and detection of cancers
US10150818B2 (en) 2014-01-16 2018-12-11 Academia Sinica Compositions and methods for treatment and detection of cancers
WO2015116902A1 (en) 2014-01-31 2015-08-06 Genentech, Inc. G-protein coupled receptors in hedgehog signaling
JP7054990B2 (ja) 2014-03-27 2022-04-15 ジェネンテック, インコーポレイテッド 炎症性腸疾患の診断及び治療のための方法
TWI797430B (zh) 2014-03-27 2023-04-01 中央研究院 反應性標記化合物及其用途
CN104012549B (zh) * 2014-05-07 2016-08-17 广东中迅农科股份有限公司 一种含有双唑草腈和双草醚的除草组合物
CN104012547A (zh) * 2014-05-07 2014-09-03 广东中迅农科股份有限公司 一种含有双唑草腈和氰氟草酯的除草组合物
JP6832709B2 (ja) 2014-05-16 2021-02-24 メディミューン,エルエルシー 新生児Fc受容体結合が改変されて治療および診断特性が強化された分子
US20150344585A1 (en) 2014-05-27 2015-12-03 Academia Sinica Anti-cd20 glycoantibodies and uses thereof
US10118969B2 (en) 2014-05-27 2018-11-06 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
FI3149045T3 (fi) 2014-05-27 2023-03-20 Academia Sinica Koostumuksia ja menetelmiä, jotka liittyvät yleisglykoformeihin vasta-aineiden parannettua tehokkuutta varten
AU2015267045B2 (en) 2014-05-27 2021-02-25 Academia Sinica Anti-HER2 glycoantibodies and uses thereof
US11332523B2 (en) 2014-05-28 2022-05-17 Academia Sinica Anti-TNF-alpha glycoantibodies and uses thereof
ES2761675T3 (es) 2014-05-30 2020-05-20 Henlix Biotech Co Ltd Anticuerpos anti-receptor del factor de crecimiento epidérmico (EGFR)
CA2955086A1 (en) 2014-08-08 2016-02-11 Alector Llc Anti-trem2 antibodies and methods of use thereof
TWI745275B (zh) 2014-09-08 2021-11-11 中央研究院 使用醣脂激活人類iNKT細胞
CN104255750A (zh) * 2014-09-10 2015-01-07 广东中迅农科股份有限公司 含有双唑草腈和丙草胺的除草组合物
WO2016073157A1 (en) 2014-11-06 2016-05-12 Genentech, Inc. Anti-ang2 antibodies and methods of use thereof
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
US9975965B2 (en) 2015-01-16 2018-05-22 Academia Sinica Compositions and methods for treatment and detection of cancers
UA123991C2 (uk) 2015-01-22 2021-07-07 Басф Агро Б.В. Трикомпонентна гербіцидна комбінація, що включає сафлуфенацил
AU2015378564A1 (en) 2015-01-24 2017-07-13 Academia Sinica Novel glycan conjugates and methods of use thereof
CN107407677B (zh) 2015-01-28 2020-07-17 豪夫迈·罗氏有限公司 多发性硬化的基因表达标志和治疗
MX2017010336A (es) 2015-02-26 2017-12-20 Genentech Inc Antagonistas de integrina beta7 y métodos para el tratamiento de la enfermedad de crohn.
WO2016161390A1 (en) 2015-04-03 2016-10-06 Eureka Therapeutics, Inc. Constructs targeting afp peptide/mhc complexes and uses thereof
PT3280441T (pt) 2015-04-07 2021-11-30 Alector Llc Anticorpos anti-sortilina e métodos para a sua utilização
CN104757013A (zh) * 2015-04-18 2015-07-08 广东中迅农科股份有限公司 含有双唑草腈和四唑酰草胺及精噁唑禾草灵的除草组合物
WO2016191811A1 (en) 2015-06-03 2016-12-08 The University Of Queensland Mobilizing agents and uses therefor
WO2016201389A2 (en) 2015-06-12 2016-12-15 Alector Llc Anti-cd33 antibodies and methods of use thereof
JP7376977B2 (ja) 2015-06-12 2023-11-09 アレクトル エルエルシー 抗cd33抗体及びその使用方法
KR102737212B1 (ko) 2015-07-10 2024-12-02 바스프 아그로 비.브이. 제초제 저항성 또는 내성 잡초의 방제 방법
CN107846892B (zh) 2015-07-10 2024-02-20 巴斯夫农业公司 包含环庚草醚和特异性喹啉羧酸的除草组合物
US11219212B2 (en) 2015-07-10 2022-01-11 BASF Agro B.V. Herbicidal composition comprising cinmethylin and imazamox
MY189197A (en) 2015-07-10 2022-01-31 Basf Agro Bv Herbicidal composition comprising cinmethylin and acetochlor or pretilachlor
SI3319437T1 (sl) 2015-07-10 2019-08-30 BASF Agro B.V. Herbicidni sestavek, ki vsebuje cinmetilin in piroksasulfon
US11219215B2 (en) 2015-07-10 2022-01-11 BASF Agro B.V. Herbicidal composition comprising cinmethylin and specific inhibitors of protoporphyrinogen oxidase
PL3319434T3 (pl) 2015-07-10 2019-11-29 Basf Agro Bv Kompozycja chwastobójcza zawierająca cynmetylinę i petoksamid
EP3319435B1 (en) 2015-07-10 2020-02-19 BASF Agro B.V. Herbicidal composition comprising cinmethylin and clomazone
CN107846893B (zh) 2015-07-10 2024-02-20 巴斯夫农业公司 包含环庚草醚和苯嘧磺草胺的除草组合物
US10813356B2 (en) 2015-07-10 2020-10-27 BASF Agro B.V. Herbicidal composition comprising cinmethylin and dimethenamid
CN105076162B (zh) * 2015-08-05 2018-03-09 安徽华星化工有限公司 一种含有乙氧氟草醚和双唑草腈的水稻田除草组合物
CN108137702B (zh) 2015-08-28 2023-01-06 艾利妥 抗siglec-7抗体及其使用方法
CN108738323B (zh) 2015-10-06 2023-05-26 艾利妥 抗trem2抗体及其使用方法
MX2018004721A (es) 2015-10-23 2018-07-06 Eureka Therapeutics Inc Construcciones quimericas anticuerpo/receptor de celulas t y usos de las mismas.
CN116003596A (zh) 2015-10-29 2023-04-25 艾利妥 抗siglec-9抗体及其使用方法
CN107847606A (zh) 2015-11-25 2018-03-27 乐高化学生物科学股份有限公司 包含自降解基团的缀合物及其相关方法
SG11201804961UA (en) 2015-12-30 2018-07-30 Genentech Inc Formulations with reduced degradation of polysorbate
WO2017152102A2 (en) 2016-03-04 2017-09-08 Alector Llc Anti-trem1 antibodies and methods of use thereof
JP2019515876A (ja) 2016-03-08 2019-06-13 アカデミア シニカAcademia Sinica N−グリカンおよびそのアレイのモジュール合成のための方法
CN105901005A (zh) * 2016-05-16 2016-08-31 河北博嘉农业有限公司 一种含有双唑草腈的除草组合物
CN105918339A (zh) * 2016-05-19 2016-09-07 河北博嘉农业有限公司 一种含有双唑草腈和磺酰脲类除草剂的除草组合物
WO2018014260A1 (en) 2016-07-20 2018-01-25 Nanjing Legend Biotech Co., Ltd. Multispecific antigen binding proteins and methods of use thereof
TWI764917B (zh) 2016-08-22 2022-05-21 醣基生醫股份有限公司 抗體、結合片段及使用方法
BR112019005129A2 (pt) 2016-09-16 2019-06-04 Shanghai Henlius Biotech, Inc. anticorpos anti-pd-1
WO2018068201A1 (en) 2016-10-11 2018-04-19 Nanjing Legend Biotech Co., Ltd. Single-domain antibodies and variants thereof against ctla-4
CN108064866A (zh) * 2016-11-15 2018-05-25 江苏龙灯化学有限公司 一种除草组合物
CN108064865A (zh) * 2016-11-15 2018-05-25 江苏龙灯化学有限公司 一种除草组合物
CN108064868A (zh) * 2016-11-15 2018-05-25 江苏龙灯化学有限公司 一种除草组合物
CN106561695A (zh) * 2016-11-15 2017-04-19 江苏龙灯化学有限公司 一种除草组合物
CN108064860A (zh) * 2016-11-15 2018-05-25 江苏龙灯化学有限公司 一种除草组合物
CN108064871A (zh) * 2016-11-15 2018-05-25 江苏龙灯化学有限公司 一种除草组合物
KR102085798B1 (ko) 2016-12-28 2020-03-06 주식회사 인투셀 베타-갈락토사이드가 도입된 자가-희생 기를 포함하는 화합물
WO2018132597A1 (en) 2017-01-12 2018-07-19 Eureka Therapeutics, Inc. Constructs targeting histone h3 peptide/mhc complexes and uses thereof
WO2018152496A1 (en) 2017-02-17 2018-08-23 The Usa, As Represented By The Secretary, Dept. Of Health And Human Services Compositions and methods for the diagnosis and treatment of zika virus infection
CN106889084A (zh) * 2017-02-27 2017-06-27 南京华洲药业有限公司 一种含双唑草腈与灭草松的除草组合物及其应用
CN106889083B (zh) * 2017-02-27 2019-02-12 南京华洲药业有限公司 一种含双唑草腈与异恶草酮的除草组合物及其应用
CN106857600A (zh) * 2017-02-27 2017-06-20 南京华洲药业有限公司 一种含双唑草腈与异丙隆的除草组合物及其应用
CN107047593A (zh) * 2017-02-27 2017-08-18 南京华洲药业有限公司 一种含双唑草腈与乙氧磺隆的除草组合物及其应用
CN106857575A (zh) * 2017-02-27 2017-06-20 南京华洲药业有限公司 一种含双唑草腈与丁草胺的除草组合物及其应用
CN106857609A (zh) * 2017-02-27 2017-06-20 南京华洲药业有限公司 一种含双唑草腈与乙氧嘧磺隆的除草组合物及其应用
CN106857577A (zh) * 2017-02-27 2017-06-20 南京华洲药业有限公司 一种含双唑草腈与氟硫草定的除草组合物及其应用
CN107047594A (zh) * 2017-02-27 2017-08-18 南京华洲药业有限公司 一种含双唑草腈与氯吡嘧磺隆的除草组合物及其应用
CN106889082A (zh) * 2017-02-27 2017-06-27 南京华洲药业有限公司 一种含双唑草腈与噁草酮的除草组合物及其应用
CN106889094A (zh) * 2017-02-27 2017-06-27 南京华洲药业有限公司 一种含双唑草腈与吡嘧磺隆的除草组合物及其应用
CN107047578A (zh) * 2017-02-27 2017-08-18 南京华洲药业有限公司 一种含双唑草腈与丙炔噁草酮的除草组合物及其应用
CN106857580A (zh) * 2017-02-27 2017-06-20 南京华洲药业有限公司 一种含双唑草腈与吡氟酰草胺的除草组合物及其应用
CN106857576A (zh) * 2017-02-27 2017-06-20 南京华洲药业有限公司 一种含双唑草腈与苯噻酰草胺的除草组合物及其应用
CN107047592A (zh) * 2017-02-27 2017-08-18 南京华洲药业有限公司 一种含双唑草腈与苄嘧磺隆的除草组合物及其应用
CN106857621A (zh) * 2017-02-27 2017-06-20 南京华洲药业有限公司 一种含双唑草腈与禾草敌的除草组合物及其应用
CN106857578A (zh) * 2017-02-27 2017-06-20 南京华洲药业有限公司 一种含双唑草腈与乙草胺的除草组合物及其应用
CN106857579A (zh) * 2017-02-27 2017-06-20 南京华洲药业有限公司 一种含双唑草腈与三嗪氟草胺的除草组合物及其应用
CN107047582A (zh) * 2017-02-27 2017-08-18 南京华洲药业有限公司 一种含双唑草腈与禾草畏的除草组合物及其应用
RU2665790C1 (ru) 2017-04-17 2018-09-04 Закрытое Акционерное Общество "Биокад" Моноклональное антитело к pd-l1
EP4230649A3 (en) 2017-04-25 2023-10-25 The U.S.A. As Represented By The Secretary, Department Of Health And Human Services Antibodies and methods for the diagnosis and treatment of epstein barr virus infection
CN110741016A (zh) 2017-04-26 2020-01-31 优瑞科生物技术公司 嵌合抗体/t-细胞受体构筑体及其用途
CN110741019B (zh) 2017-04-26 2025-06-13 优瑞科生物技术公司 特异性识别磷脂酰肌醇蛋白聚糖3的构筑体及其用途
WO2018213316A1 (en) 2017-05-16 2018-11-22 Alector Llc Anti-siglec-5 antibodies and methods of use thereof
CN106954634A (zh) * 2017-05-22 2017-07-18 娄天成 一种含双唑草腈和莎稗磷的农药组合物及其应用
CN107094781A (zh) * 2017-05-22 2017-08-29 孙金金 一种含双唑草腈和二氯喹啉酸的农药组合物及其应用
CN107114382A (zh) * 2017-05-22 2017-09-01 娄天成 一种含双唑草腈和敌稗的农药组合物及其应用
WO2018215535A1 (en) 2017-05-23 2018-11-29 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Novel cd73 antibody, preparation and uses thereof
CN107006498A (zh) * 2017-05-24 2017-08-04 江苏省农用激素工程技术研究中心有限公司 用于防除稻田杂草的除草组合物
RU2653545C1 (ru) * 2017-07-17 2018-05-11 АО "Щелково Агрохим" Гербицидная композиция на основе бентазона для защиты зернобобовых культур
CN111094334A (zh) 2017-07-19 2020-05-01 美国卫生与公众服务部 用于诊断和治疗乙肝病毒感染的抗体和方法
TWI811229B (zh) 2017-08-03 2023-08-11 美商阿列克特有限責任公司 抗trem2抗體及其使用方法
PE20200486A1 (es) 2017-08-03 2020-03-03 Alector Llc Anticuerpos anti-cd33 y metodos para utilizarlos
RU2698048C2 (ru) 2017-10-03 2019-08-21 Закрытое Акционерное Общество "Биокад" МОНОКЛОНАЛЬНОЕ АНТИТЕЛО К IL-5Rα
EA039662B1 (ru) 2017-10-03 2022-02-24 Закрытое Акционерное Общество "Биокад" Антитела, специфичные к cd47 и pd-l1
BR112020012308A2 (pt) 2017-12-19 2020-11-24 The Rockefeller University variantes domínios de igg fc humanos com função de efeito melhorada
AU2018396970B2 (en) 2017-12-28 2025-09-25 Nanjing Legend Biotech Co., Ltd. Single-domain antibodies and variants thereof against TIGIT
CN111699200B (zh) 2018-01-15 2023-05-26 南京传奇生物科技有限公司 针对pd-1的单域抗体和其变体
JP7542257B2 (ja) 2018-01-25 2024-08-30 エイシーエム バイオラブズ プライベート リミテッド 可溶化された封入抗原を含むポリマーソーム、ならびにその作製および使用方法
CN108371183A (zh) * 2018-02-02 2018-08-07 河北中天邦正生物科技股份公司 一种农药组合物及其应用
CN108308187A (zh) * 2018-02-11 2018-07-24 河北中天邦正生物科技股份公司 一种农药组合物及其应用
US11958903B2 (en) 2018-03-30 2024-04-16 Nanjing Legend Biotech Co., Ltd. Single-domain antibodies against LAG-3 and uses thereof
WO2019213416A1 (en) 2018-05-02 2019-11-07 The Usa, As Represented By The Secretary, Dept. Of Health And Human Services Antibodies and methods for the diagnosis, prevention, and treatment of epstein barr virus infection
US12227568B2 (en) 2018-06-08 2025-02-18 Alector Llc Anti-Siglec-7 antibodies and methods of use thereof
EP3806904A4 (en) 2018-06-18 2022-04-27 Eureka Therapeutics, Inc. Constructs targeting prostate-specific membrane antigen (psma) and uses thereof
PL3618928T3 (pl) 2018-07-13 2023-05-02 Alector Llc Przeciwciała antysortylinowe i sposoby ich stosowania
JP7447388B2 (ja) 2018-07-13 2024-03-12 ナンジン レジェンド バイオテック カンパニー,リミテッド 感染性疾患の治療のための共受容体システム
CA3106535A1 (en) 2018-07-27 2020-01-30 Alector Llc Anti-siglec-5 antibodies and methods of use thereof
US12247073B2 (en) 2018-08-31 2025-03-11 Alector Llc Anti-CD33 antibodies and methods of use thereof
WO2020053325A1 (en) 2018-09-12 2020-03-19 Acm Biolabs Pte Ltd Polymersomes comprising a covalently bound antigen as well as methods of making and uses thereof
AU2019338454A1 (en) 2018-09-14 2021-04-08 The Rockefeller University Anti-HIV antibody 10-1074 variants
WO2020086328A1 (en) 2018-10-25 2020-04-30 The Medical College Of Wisconsin, Inc. Targeting clptm1l for treatment and prevention of cancer
RU2724469C2 (ru) 2018-10-31 2020-06-23 Закрытое Акционерное Общество "Биокад" Моноклональное антитело, которое специфически связывается с cd20
KR20210101235A (ko) 2018-11-16 2021-08-18 메모리얼 슬로안 케터링 캔서 센터 뮤신-16에 대한 항체 및 이의 사용 방법
WO2020108423A1 (en) 2018-11-27 2020-06-04 Staidson (Beijing) Biopharmaceuticals Co., Ltd. Antibodies specifically recognizing granulocyte-macrophage colony stimulating factor receptor alpha and uses thereof
RU2734432C1 (ru) 2019-04-23 2020-10-16 Закрытое Акционерное Общество "Биокад" Моноклональное антитело, которое специфически связывается с GITR
WO2020222573A1 (ko) 2019-05-02 2020-11-05 주식회사 레고켐 바이오사이언스 트리스 구조를 가지는 링커를 포함하는 리간드-약물 접합체
US11865177B2 (en) 2019-06-28 2024-01-09 Genentech, Inc. Composition and methods for stabilizing liquid protein formulations
CN110178842A (zh) * 2019-07-05 2019-08-30 南京农业大学 一种丙草胺与双唑草腈治理抗性稗组合物及其应用
WO2021004446A1 (en) 2019-07-09 2021-01-14 Staidson (Beijing) Biopharmaceuticals Co., Ltd. Antibodies specifically recognizing pseudomonas pcrv and uses thereof
EP4004051A4 (en) 2019-07-19 2023-08-23 Oncoresponse, Inc. IMMUNOMODULATORY ANTIBODIES AND METHODS OF USE THEREOF
CN112300279A (zh) 2019-07-26 2021-02-02 上海复宏汉霖生物技术股份有限公司 针对抗cd73抗体和变体的方法和组合物
US20230220057A1 (en) 2020-05-27 2023-07-13 Staidson (Beijing) Biopharmaceuticals Co., Ltd. Antibodies specifically recognizing nerve growth factor and uses thereof
US20240092926A1 (en) 2021-01-20 2024-03-21 Oncoresponse, Inc. Immunomodulatory antibodies and uses thereof
US20250281405A1 (en) 2021-04-12 2025-09-11 Acm Biolabs Pte Ltd Polymersomes comprising a soluble encapsulated polynucleotide and an ionizable lipid as well as methods of making and uses thereof
CN118103397A (zh) 2021-07-08 2024-05-28 舒泰神(加州)生物科技有限公司 特异性识别tnfr2的抗体及其用途
JP2024525769A (ja) 2021-07-14 2024-07-12 舒泰神(北京)生物製薬股フン有限公司 Cd40を特異的に認識する抗体およびその使用
EP4445911A4 (en) 2021-12-06 2025-10-22 Beijing Solobio Genetechnology Co Ltd BISPECIFIC ANTIBODY THAT BINDS SPECIFICALLY TO KLEBSIELLA PNEUMONIAE O1 AND O2 ANTIGENS AND COMPOSITION
EP4524158A4 (en) 2022-05-09 2025-12-17 Staidson Beijing Biopharmaceuticals Co Ltd Antibody that specifically recognizes gdf15 and use thereof
EP4558226A1 (en) 2022-07-19 2025-05-28 Staidson Biopharma Inc. Antibodies specifically recognizing b- and t-lymphocyte attenuator (btla) and uses thereof
EP4596580A1 (en) 2022-09-27 2025-08-06 Staidson (Beijing) Biopharmaceuticals Co., Ltd. Antibody for specifically recognizing light and use thereof
CN120693395A (zh) 2022-10-20 2025-09-23 北京三诺佳邑生物技术有限责任公司 特异性结合TRAIL或FasL的抗体组合以及双特异性抗体
WO2025224166A1 (en) 2024-04-23 2025-10-30 F. Hoffmann-La Roche Ag Anti-drug antibody assays
WO2025233867A1 (en) 2024-05-10 2025-11-13 Adaptam Therapeutics, S.L. Anti-siglec-9 antibodies and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY136106A (en) * 1990-09-06 2008-08-29 Novartis Ag Synergistic composition comprising a sulfonylurea anda thiadiazolo (3,4-a)pyridazine and method of selective weed control.
IL116507A (en) * 1991-11-13 1997-08-14 Schering Ag Pyrazole derivatives
DK0663913T3 (da) * 1992-10-12 1999-05-03 Hoechst Schering Agrevo Gmbh Nye substituerede pyrazolderivater, fremgangsmåder til deres fremstilling samt deres anvendelse som herbicider

Also Published As

Publication number Publication date
TR199800794T2 (xx) 1998-08-21
MY114731A (en) 2002-12-31
MX9803824A (es) 1998-09-30
AU711841B2 (en) 1999-10-21
KR19990067314A (ko) 1999-08-16
BR9611478A (pt) 1999-07-13
AU7569696A (en) 1997-06-05
JP2000500445A (ja) 2000-01-18
EP0863705A1 (de) 1998-09-16
EP0863705B1 (de) 2002-06-12
ES2178720T3 (es) 2003-01-01
DE59609348D1 (de) 2002-07-18
CN1201370A (zh) 1998-12-09
UA48203C2 (uk) 2002-08-15
CN1084148C (zh) 2002-05-08
ZA969564B (en) 1997-05-15
RU2170017C2 (ru) 2001-07-10
DE19544393A1 (de) 1997-05-22
TW355125B (en) 1999-04-01
JP3920341B2 (ja) 2007-05-30
US6013605A (en) 2000-01-11
WO1997017852A1 (de) 1997-05-22
KR100427960B1 (ko) 2005-01-15
CA2236592A1 (en) 1997-05-22

Similar Documents

Publication Publication Date Title
CA2236592C (en) Synergistic herbicidal mixtures
KR101068775B1 (ko) 제초제 조성물
EP1209972B1 (en) Herbicidal composition
US5759955A (en) Herbicidal agents based on heteroaryloxyacetamides
AU2002311427B2 (en) Synergistic herbicidal compostions comprising mesotrione
HRP20010104A2 (en) Herbicides with acylated aminophenylsulfonyl urea
PL209961B1 (pl) Środki chwastobójcze zawierające podstawiony tien-3-ylosulfonyloamino(tio)karbonylotriazolin(ti)on, zastosowanie środków, sposób zwalczania niepożądanych roślin i sposób wytwarzania środków chwastobójczych
MXPA02004012A (es) Agentes herbicidas sinergisticos que contienen herbicidas del grupo de los inhibidores de hidroxifenilpiruvato dioxigenasa.
PL176089B1 (pl) Synergistyczny środek chwastobójczy oraz sposób zwalczania niepożądanej roślinności
PL220844B1 (pl) Kompozycja herbicydów na bazie sulfonylomoczników, sposób zwalczania szkodliwych roślin i zastosowanie kompozycji herbicydów
KR101148323B1 (ko) 신규한 완화제 및 이의 용도
ZA200403326B (en) Synergistic herbicidal compositions comprising herbicides from the group of the benzoylpyrazoles
US6239070B1 (en) Herbicidal mixtures
AU652481B2 (en) Synergistic herbicidal compositions
JP3300008B2 (ja) 除草剤組成物、および雑草を防除する方法
JPH04224504A (ja) 除草作用を有する組成物および雑草を防除するための方法
KR100479612B1 (ko) 1-(2-클로로-페닐)-4-(n-사이클로헥실-n-에틸-아미노카보닐)-1,4-디하이드로-5h-테트라졸-5-온및프로파닐을기본으로한선택적제초제
JPS59130803A (ja) トリアジン誘導体とレシチンまたはリノ−ル酸との組み合わせを含有する選択的除草剤
KR960007693B1 (ko) 제초제
RU2269263C2 (ru) Синергетическое гербицидное средство, включающее 2-(4-тиокарбамоил-2-фтор-5-этилсульфониламино-фенил)-4-метил-5-трифторметил-2,4-дигидро-3н-1,2,4-триазол-3-он, и способ борьбы с нежелательными растениями
SI9200224A (en) Synergistic herbicidal compositions

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20161114